146 related articles for article (PubMed ID: 35171885)
1. A Case of CD5-Positive Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type Secondary to Chronic Lymphedema.
Sun L; Sun Y; Xin W; He J; Hu Y; Zhang H; Yu J; Zhang JA
Am J Dermatopathol; 2022 Mar; 44(3):179-182. PubMed ID: 35171885
[TBL] [Abstract][Full Text] [Related]
2. A rare case of primary cutaneous diffuse large B-cell lymphoma, leg type in a patient with chronic lymphedema of the leg.
Vijaya B; Narahari SR; Shruthi MK; Aggithaaya G
Indian J Pathol Microbiol; 2019; 62(3):470-472. PubMed ID: 31361244
[TBL] [Abstract][Full Text] [Related]
3. De novo CD5-positive diffuse large B-cell lymphoma of the skin arising in chronic limb lymphedema.
Dargent JL; Lespagnard L; Feoli F; Debusscher L; Greuse M; Bron D
Leuk Lymphoma; 2005 May; 46(5):775-80. PubMed ID: 16019518
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of CD5-positive diffuse large B-cell lymphoma among Koreans: High incidence of BCL2 and MYC double-expressors.
Na HY; Choe JY; Shin SA; Kim HJ; Han JH; Kim HK; Oh SH; Kim JE
PLoS One; 2019; 14(10):e0224247. PubMed ID: 31644584
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and clinicopathologic features of CD30-positive de novo diffuse large B-cell lymphoma in Chinese patients: a retrospective study of 232 cases.
Gong QX; Lu TX; Liu C; Wang Z; Liang JH; Xu W; Li JY; Zhang ZH; Chen Q
Int J Clin Exp Pathol; 2015; 8(12):15825-35. PubMed ID: 26884853
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous B-cell lymphoma of the leg in a chronic lymphedematous extremity.
Torres-Paoli D; Sánchez JL
Am J Dermatopathol; 2000 Jun; 22(3):257-60. PubMed ID: 10871070
[TBL] [Abstract][Full Text] [Related]
7. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
8. CD5+ diffuse large B-cell lymphoma: a narrative review.
Durani U; Ansell SM
Leuk Lymphoma; 2021 Dec; 62(13):3078-3086. PubMed ID: 34284686
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic characteristics and treatment outcome of the addition of rituximab to chemotherapy for CD5-positive in comparison with CD5-negative diffuse large B-cell lymphoma.
Niitsu N; Okamoto M; Tamaru JI; Yoshino T; Nakamura N; Nakamura S; Ohshima K; Nakamine H; Hirano M
Ann Oncol; 2010 Oct; 21(10):2069-2074. PubMed ID: 20231297
[TBL] [Abstract][Full Text] [Related]
10. Double expressor and double/triple hit status among primary cutaneous diffuse large B-cell lymphoma: a comparison between leg type and not otherwise specified subtypes.
Lucioni M; Pescia C; Bonometti A; Fraticelli S; Moltrasio C; Ramponi A; Riboni R; Roccio S; Ferrario G; Arcaini L; Goteri G; Berti E; Paulli M
Hum Pathol; 2021 May; 111():1-9. PubMed ID: 33548250
[TBL] [Abstract][Full Text] [Related]
11. De Novo CD5+ Primary Gastrointestinal Diffuse Large B-Cell Lymphoma: Challenges With Treatment and Clinical Course.
Ramachandran P; Sahni S; Wang JC
J Investig Med High Impact Case Rep; 2019; 7():2324709619893546. PubMed ID: 31814435
[TBL] [Abstract][Full Text] [Related]
12. Secondary Cutaneous Diffuse Large B-cell Lymphoma has a Higher International Prognostic Index Score and Worse Prognosis Than Diffuse Large B-cell Lymphoma, Leg Type.
Lee WJ; Won KH; Won CH; Chang SE; Choi JH; Moon KC; Park CS; Huh J; Suh C; Lee MW
Acta Derm Venereol; 2016 Feb; 96(2):245-50. PubMed ID: 26014205
[TBL] [Abstract][Full Text] [Related]
13. Expression of CD29 on lymphoma cells and/or CD36 on microvascular endothels correlates with high serum LDH level in diffuse large B-cell lymphomas (DLBCLs) and is frequent in de novo CD5-positive DLBCLs.
Ueno S; Yamaguchi M; Kimura M; Odagiri H; Shiraki K; Uemoto S; Nakamura N; Zhang W; Shiku H; Kobayashi T
Int J Oncol; 2005 Nov; 27(5):1241-6. PubMed ID: 16211218
[TBL] [Abstract][Full Text] [Related]
14. De Novo CD5-Positive Diffuse Large B-Cell Lymphoma: Report of a Case Presenting With Cutaneous Involvement and Featuring Extensive Intravascular Dissemination on Postmortem Examination.
Úbeda Romero A; Santonja C; Blanco García A; Requena L; Rodríguez Pinilla SM
Int J Surg Pathol; 2016 Dec; 24(8):763-768. PubMed ID: 27431754
[TBL] [Abstract][Full Text] [Related]
15. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
16. Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomas.
Menguy S; Frison E; Prochazkova-Carlotti M; Dalle S; Dereure O; Boulinguez S; Dalac S; Machet L; Ram-Wolff C; Verneuil L; Gros A; Vergier B; Beylot-Barry M; Merlio JP; Pham-Ledard A
Mod Pathol; 2018 Aug; 31(8):1332-1342. PubMed ID: 29581544
[TBL] [Abstract][Full Text] [Related]
17. Pure intravascular recurrence of CD5-positive diffuse large B-cell lymphoma primarily arising from the nasal cavities.
Kano R; Masaie H; Hino A; Yasuoka H; Nagata S; Ishikawa J; Nakatsuka SI
Diagn Pathol; 2018 Jul; 13(1):46. PubMed ID: 30041681
[TBL] [Abstract][Full Text] [Related]
18. Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases.
Hembury TA; Lee B; Gascoyne RD; Macpherson N; Yang B; House N; Medeiros LJ; Hsi ED
Am J Clin Pathol; 2002 Apr; 117(4):574-80. PubMed ID: 11939732
[TBL] [Abstract][Full Text] [Related]
19. Immune evasion-related extranodal large B-cell lymphoma: A report of six patients with neoplastic PD-L1-positive extranodal diffuse large B-cell lymphoma.
Suzuki Y; Sakakibara A; Shimada K; Shimada S; Ishikawa E; Nakamura S; Kato S; Takahara T; Asano N; Satou A; Kohno K
Pathol Int; 2019 Jan; 69(1):13-20. PubMed ID: 30601579
[TBL] [Abstract][Full Text] [Related]
20. Utility of a Reverse Phase Protein Array to Evaluate Multiple Biomarkers in Diffuse Large B-Cell Lymphoma.
Suzuki M; Muroi A; Nojima M; Numata A; Takasaki H; Sakai R; Yokose T; Miyagi Y; Koshikawa N
Proteomics Clin Appl; 2020 Jan; 14(1):e1900091. PubMed ID: 31721454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
